150 related articles for article (PubMed ID: 18762157)
21. Aggressive surgical treatment of multidrug-resistant tuberculosis.
Shiraishi Y; Katsuragi N; Kita H; Tominaga Y; Kariatsumari K; Onda T
J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1180-4. PubMed ID: 19837220
[TBL] [Abstract][Full Text] [Related]
22. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
[TBL] [Abstract][Full Text] [Related]
23. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
[TBL] [Abstract][Full Text] [Related]
24. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
Sharma A; Khuller GK; Sharma S
Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
[TBL] [Abstract][Full Text] [Related]
25. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
[TBL] [Abstract][Full Text] [Related]
26. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
Chan ED; Strand MJ; Iseman MD
Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
[TBL] [Abstract][Full Text] [Related]
27. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
28. Opportunities for overcoming tuberculosis: new treatment regimens.
Freire MC
World Hosp Health Serv; 2006; 42(1):34-7. PubMed ID: 16669375
[TBL] [Abstract][Full Text] [Related]
29. Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.
Scano F; Vitoria M; Burman W; Harries AD; Gilks CF; Havlir D
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1370-5. PubMed ID: 19017444
[TBL] [Abstract][Full Text] [Related]
30. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.
Moulding T
Int J Tuberc Lung Dis; 2008 Sep; 12(9):1102; author reply 1102. PubMed ID: 18713512
[No Abstract] [Full Text] [Related]
31. Preclinical predictors of clinical safety: opportunities for improvement.
Sistare FD; DeGeorge JJ
Clin Pharmacol Ther; 2007 Aug; 82(2):210-4. PubMed ID: 17507920
[TBL] [Abstract][Full Text] [Related]
32. Experience with pulmonary resection for extensively drug-resistant tuberculosis.
Shiraishi Y; Katsuragi N; Kita H; Toishi M; Onda T
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1075-8. PubMed ID: 18812334
[TBL] [Abstract][Full Text] [Related]
33. Assessing non-inferiority: a combination approach.
Gao P; Ware JH
Stat Med; 2008 Feb; 27(3):392-406. PubMed ID: 17575568
[TBL] [Abstract][Full Text] [Related]
34. Latent tuberculosis infection in children: a call for revised treatment guidelines.
Finnell SM; Christenson JC; Downs SM
Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
[TBL] [Abstract][Full Text] [Related]
35. Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis.
Horsburgh CR; Haxaire-Theeuwes M; Lienhardt C; Wingfield C; McNeeley D; Pyne-Mercier L; Keshavjee S; Varaine F; ;
Int J Tuberc Lung Dis; 2013 Feb; 17(2):146-52. PubMed ID: 23211610
[TBL] [Abstract][Full Text] [Related]
36. Surrogate markers to assess new therapies for drug-resistant tuberculosis.
Wallis RS
Expert Rev Anti Infect Ther; 2007 Apr; 5(2):163-8. PubMed ID: 17402829
[No Abstract] [Full Text] [Related]
37. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
38. Drugs for tuberculosis.
Treat Guidel Med Lett; 2009 Oct; 7(86):75-82; quiz 2 p after 82. PubMed ID: 19794340
[No Abstract] [Full Text] [Related]
39. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
Kononets AS
Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
[TBL] [Abstract][Full Text] [Related]
40. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
